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Abstract: THz technologies are a powerful tool for label-free detection of biomolecules.
However, significant reduction of the lower detection limit is required to apply THz-sensors in
biomedical diagnosis. This paper reports an ultrasensitive THz-biosensor based on asymmetric
double split ring resonators (aDSRR) for the direct label- and PCR-free detection of DNA at
physiologically relevant concentrations. We introduce selective functionalization and localized
electric field concentration to enhance aDSRR sensitivity and specificity. The sensor characteris-
tics are demonstrated using the human tumor marker MIA in cDNA samples produced from total
RNA without PCR-amplification. Measurements of DNA samples with concentrations as low as
1.55 × 10−12 mol/l are presented.
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
Recent substantial developments in genomic technologies have provided possibilities for
widespread future health applications, e.g., predictive, preventive, and personalized medicine.
These advances are closely coupled with the development of powerful, reliable, and efficient
methods that can detect, analyze, and identify biomolecules, and assess their complex interactions
in biological networks. Standard bioanalytical techniques for DNA analysis still rely on ampli-
fication techniques like polymerase chain reaction (PCR) in order to obtain higher detectable
quantities and on fluorescently labeled DNA targets. Although sensitive and established, these
techniques are time consuming and require extreme caution during preparation and analysis.
There have been many attempts to develop biosensors using the so-called Lab-on-Chip technology
as it promises to be a powerful, fast, and simple tool for DNA analysis [1–3]. However, the current
methods still rely on fluorescence labeling with high system complexity. Fluorescence labeling,
as well as PCR amplification, can modify the DNA strand configuration which can introduce
diverse and unwanted interference with DNA samples, thereby corrupting the analysis [4–7].
Since resonances related to both macro- and bio-molecular interactions lie in the Terahertz
(THz) frequency range, THz sensing and analysis of biomolecules has become an attractive
alternative detection method. Vibration, torsion, and libration modes, as well as binding states
cause resonant absorptions in the THz frequency range that result in characteristicmaterial-specific
spectral fingerprints, allowing for label-free THz analysis of biomolecules [8, 9]. The label-free
sensing and analysis of biomolecules using THz radiation has already been demonstrated in the
early 2000s [10–13], proving THz sensing to be a promising technique.
The relatively large wavelength of THz waves (300 µm at 1THz) compared to the size of
biomolecules (typically < 100 nm) strongly limits its sensitivity in terms of the minimum number
of biomolecules that can be detected by a spectroscopic THz sensing approach. Frequency-
selective surfaces (FSS) with a resonance frequency in the THz range may significantly enhance
THz sensitivity [14]. FSS are based on a periodic array of resonant metallic structures, designed
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to create a sharp resonance in the frequency response [15]. By applying a dielectric load
to the FSS, the resonance frequency is detuned, resulting in a shift in resonance frequency
compared to the unloaded FSS. In THz biosensing, this sensitive mechanism is used to detect
biomolecules [14, 16].
However, despite of such advances, the sensitivity of THz sensing techniques is still several
orders of magnitude lower than state-of-the-art bioanalytical sensing techniques. THz techniques
still require significant improvements in order to reach relevant detection sensitivities needed for
real-world applications. Numerous publications on THz analyses have measured biomolecules
with comparable molecular weights (MW) in aqueous solution and found that the sensitivity is
strongly dependent on MW: as MW increases, the minimum detectable concentration decreases
because heavier and larger biomolecules are detected more easily.
DNA composed of four 16-mer sequences with an MW of approx. 19527 g/mol, and a
concentration of 4×10−6 mol/l can be measured in aqueous solution using THz spectroscopy [17],
and for larger DNA strands with 133 base pairs (bp) with an MW of approx. 80942.1 g/mol a
minimum concentration of 1.23 × 10−9 mol/l has been reported [18]. At the protein level, bovine
serum albumin (BSA) (MW of 66400 g/mol and concentration of 7.5 × 10−5mol/l) has been
detected with THz spectroscopy in aqueous solution [19]. In contrast, established bioanalytical
tools like Enzyme-linked Immunosorbent Assays (ELISA) determine human serum albumin
(HSA) (MW of 66437 g/mol) at concentrations as low as 3.16 × 10−12mol/l, however by using
signal amplification [20]. A recent publication applied THz measurements to a liver tumor
marker using an FSS-based chip with a microfluidic structure for sample loading [21]. Prior to
the measurement, the authors removed the microfluidic channel from the FSS structure and dried
the samples using N2. Anti-alpha 1 fetoprotein antibody and antigen were measured with an
MW of approx. 150000 g/mol and a concentration of 14.6× 10−9 mol/l. This result demonstrates
the sensitivity enhancement enabled by FSS-based chips in comparison to spectroscopic THz
techniques. Despite of such advances, THz detection limits are still about a factor of 4000 less
sensitive than other established bioanalytical techniques [20].
In this paper, we present a newly developed highly sensitive THz biosensor based on selectively
functionalized FSS for the detection of DNA and an experimental evaluation of its detection
capabilities. The FSS sensing structure has been carefully designed to maximize sensitivity to
enable measurements at physiologically relevant scales. Specificity to the target biomolecule
is achieved by selective hybridization of complementary DNA (cDNA) strands. Selective
functionalization of the FSS structure is used to chemically bind single-stranded (ss) oligo- or
polynucleotide probe molecules to the biosensor surface.
High frequency excitation of the biosensor exhibits a strong concentration of the electric field
at selectively functionalized resonant structures of the FSS. We measure synthetic and human
DNA samples on our THz biosensor in ambient air using an all-electronic room temperature
THz system. We provide experimental evidence of the high sensitivity of the THz biosensor
using tumor markers produced from human RNA samples without requiring labeling nor a PCR
amplification procedure.
2. Biosensor and reader setup
2.1. Biosensor concept and design
The design of the biosensor is based on asymmetric double split ring resonator (aDSRR) arrays
(Fig. 1(a)). The size of the unit cell has a periodicity of p = 416 µm. The inner radius is
r = 96 µm, the arc width w = 20 µm, the angle ϕ1 = 42◦, and the opening angle ϕ2 = 22◦. The
design is symmetrical to an imaginary line inclined by 45◦ between the x- and y-axis (red line in
Fig. 1(a)). The design assumes a certain polarization direction of the incident wave denoted as−→
E Inc (Fig. 1(a)). The wave propagates in a direction perpendicular to the sensor surface.
Similar structures of gold aDSRRs on glass substrates were presented previously [14]. Here,
we designed the complementary structure, i.e., aDSRRs as slits in a chromium/gold/chromium
layer on a quartz glass substrate, by applying Babinet’s principle [22, 23]. This complementary
design has several advantages: (i) aDSRRs are measured in transmission mode, which is easier to
realize and handle than reflection mode; (ii) this design allows for additional optimization through
an undercut etched into the substrate, a key design feature that results in a higher sensitivity by
enabling the selective functionalization of open gold surfaces in those areas where electric field
is maximal.
Fig. 1. (a) Schematic layout of the aDSRR structure and (b) cross section of one arc of
the aDSRR (not to scale), showing the quartz substrate with the etched profile (blue) and
the lithographic chromium layers (grey) enclosing the gold layer. The biofilm (green)
is selectively functionalized on the open gold surfaces. (c) Cross-sectional SEM image
of a fabricated biosensor with the undercut etched profile. (d) Simulated distribution
of the electric field in the cross section of the aDSRR long arc. The maximum of the
asymmetric E-field is concentrated at the edge of the free-standing metallic structure.
(e) Complete biosensor with query fields consisting of aDSRR arrays of 5x5 and 7x7
elements.
To visualize the layout of the etched undercut, a schematic cross section of the freestanding
metallic structure is shown in Fig. 1(b). The E-field is highly confined at the edge of the arcs
of the aDSRRs and asymmetric towards the substrate, thereby concentrated underneath the
freestanding metal. Figure 1(d) shows the distribution of the electric field of the long arc. The
refractive index of the quartz substrate is higher than for surrounding air, making the coupling
of the E-field to the glass substrate more efficient. This results in the asymmetry of the E-field
towards the substrate. The field enhancement in the lower left edge of Fig. 1(d) is a simulation
artefact due to the sharp geometrical shape of the simulation model, which can be neglected,
since the etching process during fabrication results in a round shape (cf. Fig. 1(c)). The localized
functionalization with capture DNA is depicted in green in Fig. 1(b) as a thin film on the Au
surface. Utilizing a freestanding structure to increase sensitivity has a tradeoff with mechanical
stability. This fact has to be considered during each handling, cleaning, and preparation step.
The aDSRRs are arranged in groups of 5x5 and 7x7 elements in separated areas (query fields)
(Fig. 1(e)). The compact design allows for the configuration of up to 30 query fields, allowing
for reference and multiple experiments on one biosensor within a single measurement cycle.
2.2. Fabrication
The metallization of the aDSRR structures are fabricated on top of a 500 µm quartz substrate
(Fused Silica UV grade). The THz refractive index of fused silica is n ≈ 1.96 and remains
constant in the THz range [24]. The deposited metallization consists of a hCr1 = 10 nm chromium
layer which is the adhesive agent for a hAu = 200 nm gold layer. As surface passivation, an
additional hCr2 = 10 nm chromium layer is placed on top (cf. Fig. 1(b)). The metal is structured
using standard photolithography and wet etching processes. Subsequently, an additional wet
etching process with hydrofluoric acid (HF) is applied to make a dEtch = 3 µm deep isotropic
undercut etch (dEtch = hEtch) in the quartz substrate. This etching process creates a freestanding
metal structure (Fig. 1(c)). The isotropic HF etching profile results in an undercut of 3.08 µm by
3.33 µm, which agrees very well with the design objective. The chromium layer underneath the
freestanding metal is wet etched to uncover the gold surface at this undercut area only, in order to
allow selective biomolecular functionalization of this area. Finally, photoresist is removed and
the wafer is cleaned.
2.3. Modeling results
To evaluate and optimize the properties of the aDSRR, we used the Maxwell solver ANSYS HFSS
for electromagnetic modeling. The aDSRR unit cell was simulated as a repetitive element with
periodicity p and periodic boundary conditions. Gold was modeled with a dielectric constant
εr = −1.12 × 105 and conductivity σ = 4.01 × 107 S/m. These parameters were calculated from
the complex dielectric function of the Drude model [25]. Chromium layers were not modeled, as
due to the low thickness of the layer, no influence on the simulation results can be observed. The
material properties of quartz glass are εr = 3.81 with a dielectric loss tangent δ = 0.0001 [24,26].
The modeling of the dielectric loading applied through the DNA film is particularly challenging
due to the vast difference in DNA molecule size compared to the THz wavelength, and the
shortage of reliable data on the dielectric properties of DNA in the THz range.
Few attempts have been made to determine the physical properties of DNA in the THz
frequency range. In [11] the refractive index of large DNA with a mass of ∼ 12 × 106 g/mol
was measured as n ≤ 1.5. Brucherseifer et al. [10] worked out the difference between denatured
and hybridized DNA samples for large DNA molecules (5.4 kb) in thick layers (30 µm). It was
obtained n ≈ 1.05 for denatured and n ≈ 1.175 for hybridized DNA at a frequency of 1.25THz.
However, the DNA samples were arranged differently in our study: as short DNA strands (24 -
25 bp) functionalized on a gold surface. The DNA molecules self-assembled on a film but not
all binding sites were occupied. Therefore, these samples act in a different manner than dry
disordered samples of 30 µm bulk DNA. Previous experiments with denatured and hybridized
DNA on a stripline dipole resonator have shown a frequency shift that is 2600 times larger than
expected by simulation results [27, 28]. These experiments clearly demonstrate the different
behaviour of bulk DNA compared to self-assembled monolayers of DNA on a sensor surface. As
a consequence, a comparative simulation and experimental analysis loading the sensors with
DNA and with a polymer film was performed [29]. The resulting frequency shift caused by the
dielectric loading with a polymer film is comparable to the shift caused by the self-assembled
DNA film. This demonstrates that it is viable to simplify simulations by exchanging the extremely
thin DNA film by a 100 nm PMMA film [30]. Our model for the DNA film is approximated
as a 100 nm thick PMMA layer with the material parameters εrDNA = 2.6, bulk conductivity
σ = 100 kS/m, and dielectric loss tangent δ = 0.001 [31], therefore. This model was verified
by comparing simulation results with measurements to ensure that it correctly describes the
dielectric loading of DNA on the aDSRR in simulations. In order to determine the shift of the
position of the resonance frequency as a result of the dielectric loading with the DNA model
system, the DNA (blue curve in Fig. 2) in the simulation model was exchanged with air as a
reference (green curve in Fig. 2, εr Air = 1). The shift of the resonance frequency was then
calculated by the difference of reference and DNA model system.
Fig. 2. Simulated transmission spectra for the designed aDSRR structure of reference
and simulated DNA loading. The peak-to-peak transmission intensity difference of
both resonance features is ∼ 23 dB with an 8.5GHz width. Comparing the center
frequencies of both simulations, a shift of ∆ f = 0.76GHz towards lower frequencies is
observed as a result of DNA loading.
The superposition of the resonances of each split ring arc results in a Fano-type double resonance
feature (DRF) in the simulated transmission spectrum (Fig. 2). The properties of the DRF are
given by the maximum and minimum transmissions, the peak-to-peak transmission intensity
difference (∼ 23 dB), width 8.5GHz, and flank steepness −2.71 dB/GHz. The position of the
resonance featurewas determined through a linear fit function of the resonance flank between 289.8
and 292.6GHz, which contains the inflection point. We determined the position of the resonance
frequency exclusively from the linear part of the resonance feature at FResonance = 291GHz
with the inflection point at −16 dB. This fitting method is essential to determine the position
of the resonance frequency at the intersection level at −16 dB, which is in the center between
maximum and minimum of the DRF. The linear fitting ensures the robust detection of the
resonance frequency and thus a reproducible and repeatable determination of the frequency shift.
As a results of the dielectric loading with the DNA model system, its resonance frequency was
shifted by about 0.76GHz towards lower frequencies compared to the reference. Please note that
the absolute position of the DRF in the measurement results was lower (see Section 3) as a result
of the shape variation of the fabrication process in comparison to the simulation model. However,
as we are interested in relative frequency shifts, the absolute DRF position is irrelevant.
2.4. Measurement setup: biosensor reader
Traditional THz measurement systems for material analysis and characterization typically use
time domain spectroscopy (THz-TDS) consisting of photoconductive antennas for THz generation
and electro-optical sampling [26, 32, 33]. These systems generate a frequency spectrum that has
a bandwidth of several THz, but limited resolution. Therefore, THz-TDS systems are not suitable
to detect small resonance shifts.
We used a robust and frequency-stable all-electronic THz spectroscopy system in transmission
mode for our biosensor measurements, therefore. This system provides a signal-to-noise ratio
over 40 dB and can detect small frequency shifts below 6MHz. The biosensor was positioned
by motorized stages with 5 µm position repeatability in all three directions, allowing a very
high measurement reproducibility for consecutive measurements after different biochemical
procedures. The all-electronic measurement scheme is based on quasi-heterodyne detection: a
voltage-controlled oscillator (VCO), modulated by a continuous saw-tooth signal, generating a
local oscillator (LO) frequency of 12 − 18GHz. The LO signal is multiplied by a factor of 18 in
a frequency multiplier chain, which results in an operating frequency range of 220 − 320GHz.
Consequently, measuring one query field takes 110ms, including signal processing. A more
detailed description of the setup is provided in [34].
2.5. Sample preparation and methods
Two kinds of measurements were performed: (1) using ex-situ hybridized synthetic DNA to test
functionalization dependencies, and (2) using total RNA derived from pathological samples of
human origin (including melanoma inhibitory activity (MIA) mRNA) in an on-chip hybridization
to mimic typical biosensor applications.
Initially, the chips were cleaned of residues, especially organics, with piranha solution (H2SO4
: H2O2, 3:1) for 2 h at 75 ◦C. After cleaning, the remaining piranha solution was washed away by
intensive rinsing with deionized (DI) water. The chip was dried in a nitrogen flow and placed in
an oven at 50 ◦C for 45min.
The functionalization of the capture oligonucleotides is based on thiol-gold binding [35].
All capture probes were modified at their 5′-ends with a thiol group, allowing for localized
functionalization to the undercut etched gold surface due to the specific binding of thiol to gold.
The functional thiol group was protected by mercaptohexanol (MCH), forming a disulfide bond.
Prior to use, the disulfide was deprotected with tris(2-carboxyethyl)phosphin (TCEP). After each
functionalization step, 1mM MCH solution removed unspecific bindings of adsorbed DNA. The
MCH forms a self-assembling monolayer (SAM) and improves the accessibility of the captured
oligonucleotides for the target DNA. Therefore, the hybridization efficiency is maximized and
the fully covered surface suppresses nonspecific adsorption to the gold surface [36].
Each functionalization and hybridization steps involvedmanually pipetting 3 µl sample volumes,
forming a droplet, which was left for 45min on the biosensor at room temperature to ensure
functionalization and hybridization were successful. After, the biosensor was rinsed with DI
water to remove residues. In the last step the biosensor was dried with nitrogen and tempered at
50 ◦C for 45min, followed by biosensor measurement. All measurements were performed in dry
state to prevent distortion caused by water molecules. The drying process of the double-stranded
(ds) DNA does not affect the bound cDNA, having no influence on results.
For the unequivocal identification of frequency shifts in a query field, each biochemical process
step was followed by a complete measurement of the biosensor. The frequency shift of each query
field was determined by comparing the positions of the resonance feature of two measurements.
The frequency shift on unloaded query fields were used as reference. Reference measurements
are vital to control and monitor shifts, which may result from unwanted chemical or mechanical
effects.
2.5.1. Preparation of ex-situ hybridized synthetic DNA
Ex-situ, in this context, is the hybridization process of capture and target DNA in buffer solution.
The hybridization process was performed in a tube filled with buffer solution in a thermoshaker
for 8 h at 50 ◦C, below the melting temperature for this dsDNA (67.8 ◦C). Once hybridization
was complete, separated sulfides were removed in Bio-Spin®P-6 Gel Columns centrifuged at
1000 g for 4min with hybridization buffer (1MNaCl, 10mM Tris-HCl, 1mM EDTA, and NaOH
to adjust to pH 7.5). Denaturation of dsDNA was performed with 8M solution of CO(NH2)2
(UREA) for 45min.
The 25 bp DNA sequence derived from beta-actin mRNA is: 5′-THI-TGG-CAC-CAC-ACC-
TTC-TAC-AAT-GAG-C-3′ for the capture and 5′-G-CTC-ATT-GTA-GAA-GGT-GTG-GTG-
CCA-FLU-3′ for target probes, hereinafter referred to as SYN1. The 24 bp DNA sequence derived
fromMIA mRNA is: 5′-THI-GGT-CCT-ATG-CCC-AAG-CTG-GCT-GAC-3′ for the capture and
5′-GTC-AGC-CAG-CTT-GGG-CAT-AGG-ACC-FLU-3′ for target probes, hereinafter referred
to as SYN2. The fluorescence marker at the 3′-end of the target probe enables further analysis
without affecting THzmeasurements. The oligonucleotides were ordered fromEurofins Genomics
GmbH.
2.5.2. Preparation of on-chip hybridized copy DNA
On-chip hybridization is the process of cDNA strands hybridizing to the biosensor surface.
Functionalization was performed with the thiol modified synthetic capture probe SYN2, described
above. This sequence is able to capture one specific cDNA, MIA, of the total cDNA sequences
prepared from total RNA isolated from the human melanoma cell line (with the share of MIA
cDNA being as low as 0.000048%). The specific detection of one of these cDNA molecules
covers the typical case of application of medical diagnosis. To measure endogenous DNA
molecules, aliquots of 100 µl containing cDNA from the melanoma cell line Mel Im were
produced. Isolation of the total RNA was carried out after pelleting the melanoma cells cultured
in vitro (∼ 3 million cells per pellet). To perform the isolation, the manufacturer’s protocol
of the E.Z.N.A.® Total RNA Kit I (Omega Bio-tek) was followed. Subsequently, 500 ng RNA
was reverse transcribed in a volume of 20 µl following the manufacturer’s protocol of reverse
transcriptase SuperScript™ II (Invitrogen AG) at 37 ◦C for 45min using dN6 primer. The reverse
transcriptase reaction buffer system contains 1 µl reverse transcriptase II, 4 µl First-Strand Buffer
(250mM Tris-HCl (pH 8.3), 375mM KCl, 15mM MgCl2), 2 µl 0.1M DTT, 1 µl 10 µM dNTPs
(Genaxxon bioscience GmbH), 1 µl random primer dN6 (Roche Deutschland Holding GmbH)
and H2O bidest. adding up to 20 µl. Subsequently, the remaining RNA was digested by adding
1 µl RNase and incubating for 30min at 37 ◦C. No additional PCR amplification was performed
in this study, therefore the generated amount of cDNA reflects 1:1 the endogenous amount of
RNA.
The functionalization and measurement process begins with the initial functionalization of
the query fields with 20 µM ssDNA of the synthetic capture SYN2 sequence. The measurement
fields were subsequently treated with 1mMMCH for 45min to remove unspecific bound ssDNA.
Next, 8M UREA was pipetted on query fields which were initially functionalized with dsDNA
(data not shown). Finally, the on-chip hybridization occurred by adding the complementary
ssDNA sequence of 3 µl cDNA generated as described above. Each process step was followed by
cleaning: DI water rinse, nitrogen drying, and tempering at 50 ◦C for 45min. Measurement of
the biosensor followed each step.
3. Results and discussion
3.1. Functionalization dependency test with ex-situ hybridized dsDNA
To verify functionalization and hybridization processes, the biosensor was tested with the ex-situ
hybridized dsDNA sequences SYN1 and SYN2. Ex-situ dsDNA is particularly convenient because
hybridization efficiency in solution is high compared to on-chip hybridization. Additionally, it is
an established preparation step prior to on-chip hybridization.
Fig. 3. (a) Representative transmission spectra of four measurements at two query
fields. The resonance frequency FR of each measurement was determined by a fitting
and analyzed at −15 dB. A frequency shift of ∆ f1 = −314MHz is observed for the
query field loaded with 5 µM dsDNA in comparison the frequency shift ∆ f2 of the
reference field is negligibly small (b).
Prior to the experiment, the biosensor was cleaned with piranha solution. The first measurement
is the reference for all measurements, referred to as "Clean Ref. Field" and "Clean Meas. Field",
see the transmission spectra in Figure 3(a). In the following measurement, one field (green
curves) was untreated while the second query field was functionalized with the ex-situ hybridized
5 µM dsDNA sequence SYN1 (blue curves). The DRF on the second query field is shifted by
∆ f1 = 314MHz towards lower frequencies in relation to the clean measurement field (cf. in
Figure 3(a) "Clean Meas. Field" and "5 µM dsDNA"). Comparing the measurements "Clean
Ref. Field" and "Ref. Field", the frequency shift ∆ f2 for the reference field increases by 15MHz.
Figure 3(b) represents the frequency shifts ∆ f1 for the query field functionalized with 5 µM
dsDNA and ∆ f2 used as reference. In order to determine statistically relevant data, each biosensor
was measured ten times consecutively. These values were used to calculate the mean and
experimental standard deviation (maximum 6MHz, see Fig. 3(b)).
The second experiment was a series of measurements using the 24 bp dsDNA sequence SYN2
derived from MIA with concentrations varying between 20 µM and 0.1 µM. Figure 4 depicts
the measured frequency shift towards lower frequencies dependent on dsDNA concentration in
order to assess the selective functionalization efficiency. The experiment was performed on one
biosensor in different query fields, which were functionalized with ex-situ hybridized dsDNA.
The frequency shift reaches from 801MHz for 20 µM dsDNA concentration to 5.5MHz for
0.1 µM dsDNA. A distinct correlation between surface occupation and the shift of the position
of the resonance frequency is evident. The lowest concentration reaches the lower limit of our
detection range and the lowest reliable detectable ex-situ hybridized dsDNA concentration is
1 µM. Please note that this variation of the density thiol group containing dsDNA does measure
the functionalization efficiency and not the application relevant on-chip hybridization detection
concentration requirements, as shown below.
3.2. Application evaluation with on-chip hybridized cDNA
On-chip hybridization experiments were performed to demonstrate the application relevant levels
for dsDNA detection. Experiments with the synthetic DNA sequence SYN2 and with human
Fig. 4. Measured frequency shift caused by loading the biosensor with hybridized
24 bp dsDNA SYN2. Variation in DNA concentration between 20 and 0.1 µM has a
dependency related to the frequency shift towards lower resonance frequencies.
melanoma cell line MIA cDNA sample produced from total RNA (without PCR-amplification)
are carried out. The amount of MIA cDNA in the sample is as low as 4.64 × 10−18mol with a
molecular weight of 7378 g/mol. This amount was calculated by determining the share of MIA
mRNA in the isolated total RNA samples using RNA-Seq data sets of the melanoma cell line Mel
Im as 0.000048% and the amount of total RNA used in the experiment. The measurement results
are shown in Figure 5(a). The colored boxes define different query fields, whereby the green box
is the untreated reference field, the red is the on-chip hybridization with 20 µM synthetic SYN2
sequence, and the blue box is the on-chip hybridization with 1.55 × 10−12mol/l PCR-free MIA
cDNA sample. Fig. 5(b) depicts the biosensor query fields loaded with various samples.
The red bars in Figure 5(a) are the frequency shifts as a result of the functionalization,
compared to the initial measurement of the query field. The resonance frequency on the reference
field remains at the same position, compared to the fields which were functionalized: a shift
of −36MHz on the SYN2 field and −85MHz on the MIA cDNA field. The blue bars (MCH
treatment) depict an additional slight shift towards lower resonance frequencies when compared
to the functionalized case. Since the same shift appears on all measured fields, including
the reference field, it must be due to mechanical and chemical handling. UREA was used to
denature dsDNA and had no influence on the ssDNA, resulting in negligible changes in resonance
frequency. The frequency shift from the hybridization process is shown in green, yielding
to −270MHz for the SYN2 sequence and −230MHz for MIA cDNA, relative to the initial
measurement of the biosensor. Compared to the functionalized resonance frequency (blue bars),
the shift is −234MHz and −145MHz for SYN2 and MIA cDNA, respectively.
3.3. Discussion
The transmission spectra of simulation and experimental results are consistent. The peak-to-peak
transmission intensity differences of the measured aDSRR structure is 10 dB over a frequency
Fig. 5. (a) Relative frequency shifts towards lower frequencies as a consequence of
different DNA sequences which are functionalized on different query fields (indicated
by green, red, and blue boxes) on one biosensor. The colored bars indicate the process
steps: red is the functionalization with thiol modified capture DNA, blue the treatment
with MCH, pink rinsing with UREA, and green the on-chip hybridization with the
target sequences SYN2 and MIA cDNA. The biosensor loaded with various analytes is
illustrated in (b).
range of 7GHz. Compared to simulations, the peak-to-peak transmission intensity is lower,
as a result of the finite array, the losses from the materials and limited conductivity of gold
and chromium. However, the width and relative frequency shift of the resonance feature are in
agreement with model results.
The first experiments are performed to verify the efficiency of the functionalization procedures.
Experimental functionalization dependencies with the ex-situ hybridized 25 bp dsDNA SYN1
and the 24 bp dsDNA SYN2 sequence, show a distinct frequency shift, while the simultaneously
measured reference field displays no significant shift. The correlation between frequency shift
and dsDNA concentration clearly demonstrates the capability of the biosensor to detect short
dsDNA strands at various concentrations, down to a limit of 1 µM for ex-situ hybridized dsDNA.
The efficiency of ex-situ hybridization in these experiments is at its maximum due to the long
interaction time span, controlled temperature, and mixture with buffer solution. The detectable
frequency shift is therefore only limited by the number of functionalized capture DNA molecules,
which are bound to the gold surface and is directly proportional to dsDNA concentration. Higher
absolute shift levels would be expected. The reason for the limitation in the functionalization
process is not fully understood since the query fields are loaded with similar probes and processed
consecutively. Conceivable reasons are that the single query fields were not fully cleaned of
residues from the fabrication. Furthermore, the efficiency of the functionalization process is
unknown, since the gold surface on the bottom of the freestanding metal is hard to access
for the thiol-modified DNA. We also assume that the texture of the gold surface reduces the
functionalization density and the efficiency of the process. Therefore, the functionalization
process needs to be optimized for improved reproducibility. However, the experiments verify the
functionalization and hybridization capability of the sensor fabrication process and demonstrate
the selective functionalization efficiency of our biosensor.
The second experiment represents an application evaluationwith pathological samples produced
from the humanmelanoma cell lineMel Im. The on-chip hybridization experiment was performed
with the synthetic DNA SYN2 and the MIA cDNA as target probes, hybridized on the biosensor
surface. The shift caused by the on-chip hybridization with MIA cDNA is remarkable, since the
MIA cDNA shift reaches 62% in comparison to the synthetic SYN2 results. This is particularly
notable in view of future THz biosensor applications since the concentration of MIA cDNA is
seven orders of magnitude smaller than the one of the synthetic SYN2 sequence. This clearly
indicates a close to perfect on-chip hybridization efficiency (on the order of 62%) and a limited
efficiency of the functionalization process. The absolute number of capture DNA molecules,
which are available for the on-chip hybridization process, is equivalent to the number of dsDNA
molecules during the ex-situ hybridization experiments. The results indicate that we reached a
saturation level in the measurements with ex-situ hybridized synthetic SYN2, whereas in the
on-chip hybridization, the ratio of available capture molecules to applied MIA cDNA allows
for an almost equivalent frequency shift. The number of hybridized molecules of MIA cDNA
and synthetic SYN2 is therefore almost the same despite the lower concentration of MIA cDNA
(1.55 × 10−12 mol/l).
Fig. 6. (a) In comparison to published THz results, our measurements show increased
sensitivity by six orders of magnitude at comparable molecular weights. The dashed
line represents the overall trend of decreasing detection limits with increasing molecular
weight. (b) Table with best of class THz analyses of biomolecules.
In comparison to state-of-the-art research results of biosensing in the THz range, the detection
of MIA cDNA at a PCR-free concentration of 1.55× 10−12 mol/l is remarkable. The total amount
of molecules is as low as 4.64 × 10−18 mol of MIA cDNA, with a droplet size of 3 µl. Fig. 6(a)
shows a collection of best of class THz measurements of biomolecules (red dots) with different
MW indicating the lower detection limit of these analyses [17,18,21,37]. The dashed line in Fig.
6(a) indicates the dependency of the minimum detectable concentration on MW with the slope of
m = −1.45 [38]. A clear trend is visible: the higher MW, the lower the detectable concentration
of biomolecules.
Our result for PCR-free MIA cDNA reaches a sensitivity roughly six orders of magnitude better
than existing approaches for biomolecules with comparable MW. On top of the high sensitivity,
our approach is highly specific to the target DNA by utilizing the highly selective hybridization
process of cDNA strands. Specificity, achieved by functionalization of the sensor surface using
capture probe molecules (i.e. ss oligonucleotides), which are chemically bound to the biosensor
surface, is a second key feature for bioanalytical applications addressed with our biosensor.
4. Conclusion
In this work, we present the development, fabrication, and practical use of a THz biosensor
for the tumor-related analysis of DNA samples. Based on electromagnetic field simulations,
the design was optimized to maximize sensitivity through selective functionalization, undercut
etched structures, and resonance of the split ring resonators. The resonance frequency was
determined with an accuracy of 6MHz in an all-electronic spectroscopic system at a center
frequency of 280GHz. The use of the biosensor for the detection of synthetic and human
DNA samples was experimentally verified by ex-situ and on-chip hybridization in different
concentrations which were reproduced in model simulations. We detected a frequency shift of
230MHz for MIA cDNA and 270MHz for a synthetically produced DNA sequence. Highly
specific hybridization of MIA cDNA enables the detection out of a vast number of various
DNA molecules, which mimics the typical case of real-world applications for medical diagnosis.
Most importantly, the experimentally determined lower detection limit is 1.55 × 10−12mol/l
for MIA cDNA without PCR amplification, equal to 4.64 × 10−18mol of molecules. These
results are by six orders of magnitude better than published THz results. With the demonstrated
exceptionally high PCR-free sensitivity combined with a very high specificity, achieved by
biochemical sensor functionalization, we addressed two key features for biosensor application.
Our biosensor outperforms existing approaches in two essential aspects: PCR-free sensitivity and
specificity, paving the way for a broader implementation and use of THz biosensing techniques.
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